Cite
Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery
MLA
Zhenjiang Guo, et al. “Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.” Frontiers in Oncology, vol. 12, June 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.908229.
APA
Zhenjiang Guo, Honghai Guo, Yuan Tian, Ze Zhang, & Qun Zhao. (2022). Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.908229
Chicago
Zhenjiang Guo, Honghai Guo, Yuan Tian, Ze Zhang, and Qun Zhao. 2022. “Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.” Frontiers in Oncology 12 (June). doi:10.3389/fonc.2022.908229.